Eli Lilly – TOP DAILY NEWS

Dec122024 by adminNo Comments

Elon Musk is on the weight-loss drug bandwagon

Business

In This StoryElon Musk, the wealthiest individual alive and the co-head of President-elect Donald Trump's brand-new Department of Government Efficiency (DOGE), is doubling down on his assistance for broadening access to inexpensive GLP-1 weight-loss medications like Ozempic.Recommended ReadingWhat Steve Jobs may have made with AI: Insights from his previous intern Chet KapoorRecommended Reading"Nothing would do more to enhance the health, life-span and lifestyle for Americans than making GLP inhibitors very low expense to the general public. Absolutely nothing else is even close," Musk composed Wednesday early morning in a post on X, the social networks website he owns.GLP-1 medications are a class of drugs made popular by Novo Nordisk's diabetes treatment, Ozempic. These drugs imitate a ...

FDA Approves Donanemab for Early Alzheimer’s

Health and Mediacal

The United States Food and Drug Administration (FDA) has actually authorized Eli Lilly's anti-amyloid donanemab (Kisunla) 350 mg/20 mL once-monthly injection for intravenous infusion for grownups with early symptomatic Alzheimer's illness (ADVERTISEMENT), that includes moderate cognitive problems (MCI) or moderate dementia phase of illness with verified amyloid pathology.Once-monthly donanemab is "the very first and only amyloid plaque-targeting treatment with proof to support stopping treatment when amyloid plaques are eliminated, which can lead to lower treatment expenses and less infusions," Eli Lilly stated in a declaration revealing approval."This is genuine development. Today's approval enables individuals more choices and higher chance to have more time," stated Joanne Pike, DrPH, A...

Viagra and Alzheimer’s; Migraine Consensus Statement; FDA Updates Drug Guidance

Health and Mediacal

Neurology > > General Neurology-- News and commentary from the world of neurology and neuroscience by Judy George, Deputy Managing Editor, MedPage Today March 12, 2024 More information supported links in between the impotence drug sildenafil (Viagra) and decreased Alzheimer's danger. (Journal of Alzheimer's Disease The American Headache Society provided an agreement position declaration stating drugs targeting calcitonin gene-related peptide are a first-line choice for migraine avoidance. (Headache Eli Lilly stated the FDA will hold an advisory committee conference to go over the stage III TRAILBLAZER-ALZ 2 trial of ...